Skip to content
25I-NBOH

Structure via PubChem · Public domain (PubChem)

EntityQ4632139· pop 5· linked from 1,592 articles

Also known as Cimbi-27

25I-NBOH (NBOH-2C-I, Cimbi-27, 2C-I-NBOH) is a derivative of the phenethylamine-derived hallucinogen 2C-I that was discovered in 2006 by a team at Purdue University. It is a known metabolite of 25I-NBOMe and has also been encountered as a novel designer drug.

Chemical data

Formula
C17H20INO3
Molecular weight
413.25 g/mol
IUPAC name
2-[[2-(4-iodo-2,5-dimethoxyphenyl)ethylamino]methyl]phenol
SMILES
COC1=CC(=C(C=C1CCNCC2=CC=CC=C2O)OC)I
InChIKey
FEUZHYRXGQTBRO-UHFFFAOYSA-N
XLogP
4
Polar surface area
50.7 Ų
H-bond donors
2
H-bond acceptors
4
Formal charge
0

via PubChem

Wikidata facts

Mass
413.048792
Show 2 more facts
chemical formula
C₁₇H₂₀INO₃
canonical SMILES
COC1=CC(=C(C=C1CCNCC2=CC=CC=C2O)OC)I
Sources (2)

via Wikidata · CC0

~4 min read

Encyclopedic overview

16 sections
Contents
  • Use and effects
  • Interactions
  • Pharmacology
  • Pharmacodynamics
  • Chemistry
  • Analysis
  • Analogues
  • History
  • Society and culture
  • Legal status
  • Canada
  • Sweden
  • United Kingdom
  • United States
  • See also
  • References

25I-NBOH (NBOH-2C-I, Cimbi-27, 2C-I-NBOH) is a derivative of the phenethylamine-derived hallucinogen 2C-I that was discovered in 2006 by a team at Purdue University. It is a known metabolite of 25I-NBOMe and has also been encountered as a novel designer drug.

==Use and effects== The dose range of 25I-NBOH is 300 to 1,000μg, with an estimated typical dose of 700μg. The route of administration is sublingual or buccal.

Excerpted from Wikipedia’s “25I-NBOH” article, available under the CC BY-SA 4.0 licence.

Available in 5 languages

via Wikidata sitelinks · CC0